Brief: Biomed Lublin Says Onko BCG Gets Market Authorisation In Germany And Switzerland

Synthaverse SA

25/08/2022 11:17

Aug 25 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * APOGEPHA ARZNEIMITTEL INFORMS IT HAS OBTAINED GERMAN AND
SWISS
MARKET AUTHORISATION FOR ONKO BCG
    * PRODUCT IS USED TO TREAT BLADDER CANCER

Source text for Eikon:  ID:nEM2LgJWXa 
Further company coverage:  BML.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))